Figure 1
Duration of major cytogenetic response with nilotinib. Only 5 (4%) of the 134 patients who had achieved major cytogenetic response discontinued due to progression or death.
Duration of major cytogenetic response with nilotinib. Only 5 (4%) of the 134 patients who had achieved major cytogenetic response discontinued due to progression or death.
